NCT03324126

Brief Summary

Objectives: To compare the effects of two different methods of individualized protein fortification of breast milk on the early growth of VLBW preterm infants. Design: VLBW preterm infants ≤ 32 weeks of gestational age were included in the study and randomized into two groups according to the method of breast milk fortification. In the targeted protein fortification group, breast milk samples were analyzed daily via mid-infrared spectroscopy and additional protein was provided to maintain an intake of 4.5 g/kg/day. In the adjustable protein fortification group, blood urea nitrogen (BUN) levels were monitored weekly, and if the level was \< 5 mg/dL, the amount of protein fortification was gradually increased to an "estimated" maximum level of 4.5 g/kg/day, as per the policy of neonatal intensive care unit. The cumulative amounts of protein, energy, fat, and carbohydrate given to infants prior to study commencement and during the study period were calculated. Anthropometric measurements were performed in both groups weekly for 4 weeks to compare their growth, and blood data including pH, base deficit, and urea, creatinine, and albumin levels were collected.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2013

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2014

Completed
3.6 years until next milestone

First Submitted

Initial submission to the registry

September 30, 2017

Completed
27 days until next milestone

First Posted

Study publicly available on registry

October 27, 2017

Completed
Last Updated

October 27, 2017

Status Verified

October 1, 2017

Enrollment Period

3 months

First QC Date

September 30, 2017

Last Update Submit

October 24, 2017

Conditions

Keywords

Preterm infantsvery low birth weightbreast milkindividualized fortificationtargeted protein fortificationadjustable protein fortificationgrowth

Outcome Measures

Primary Outcomes (3)

  • Weight gain

    The mean of weight gain (g/kg/day)

    4 weeks

  • Head circumference

    The mean of head circumference (mm/week)

    4 weeks

  • Length

    The mean of length (mm/week)

    4 weeks

Secondary Outcomes (8)

  • Blood Urea Nitrogen (BUN)

    4 weeks

  • Albumin

    4 weeks

  • Base deficit

    4 weeks

  • Protein content

    4 weeks

  • Calorie intake

    4 weeks

  • +3 more secondary outcomes

Study Arms (2)

Targeted fortification

In the targeted protein fortification group, breast milk samples were analyzed daily via mid-infrared spectroscopy and additional protein was provided to maintain an intake of 4.5 g/kg/day.

Adjustable fortification

In the adjustable protein fortification group, blood urea nitrogen (BUN) levels were monitored weekly, and if the level was \< 5 mg/dL, the amount of protein fortification was gradually increased to an "estimated" maximum level of 4.5 g/kg/day

Eligibility Criteria

Age25 Weeks - 32 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Very-low-birth-weight preterm infants ≤ 32 weeks of gestational age were included in the study and randomized into two groups according to the method of breast milk fortification.

You may qualify if:

  • \- Very-low-birth-weight preterm infants ≤ 32 weeks of gestational age who were fed exclusively fortified breast milk.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Zeynep Ince, Prof.

    Istanbul University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 30, 2017

First Posted

October 27, 2017

Study Start

September 1, 2013

Primary Completion

December 1, 2013

Study Completion

February 28, 2014

Last Updated

October 27, 2017

Record last verified: 2017-10